más de 350.000 notas de prensa publicadas  
agencia internacional de noticias
notas de prensa
publicar
24 horas
mapa
noticias gratis
 
  ¿Qué? |¿Por qué?| Servicios | Contenidos |Aprenda Contratar Busca y compra online compras Busca millones de vídeos vídeos

  busca y recomienda millones de vídeos  
noticia patrocinada
noticias.info: publique ilimitadas notas de prensa y envíelas a todos los medios de España por sólo 299€/año
 

 


  Google
  Internet
noticias.info


Archivo > 2008 > Junio > Miércoles 25 > noticia n° 365.457





Fuente: © Oracle Corporation
http://www.oracle.com/

ORACLE: India’s Largest Independent Clinical Research Organization Improves R&D Efficiency with Oracle

Over 500 SIRO Clinpharm Researchers In More Than 150 Clinical Studies Use Oracle® Clinical Applications

/noticias.info/ * SIRO Clinpharm Pvt Ltd (SIRO), India's largest independent, full-service clinical research organization (CRO) is using Oracle(r) clinical applications to improve R&D efficiency and customer responsiveness.
* Established in 1996, SIRO offers end-to-end clinical research services, with clinical trials management and clinical data management as its core operations. SIRO required a best-in-class solution that was robust and could rapidly scale to meet the company's growth demands.
* Oracle's clinical applications are helping SIRO speed up information gathering and reduce the need for paper documentation.
* *Oracle's clinical applications enable CROs to improve R&D efficiency by:
o Enhancing operational efficiencies and outcomes in clinical trial management
o Increasing efficiency and quality of clinical data with electronic data capture
o Streamlining analysis, reporting and submission of integrated clinical and non-clinical data
o Improving clinical trial decision-support with clinical analytics
* Oracle's integrated suite of applications and infrastructure software for clinical development includes Oracle Clinical, Oracle Remote Data Capture, Oracle Thesaurus Management System, Oracle Adverse Event Reporting System, Oracle Life Sciences Data Hub, and Oracle's Siebel Clinical Trial Management System. These solutions provide a streamlined system for managing large volumes of patient data collected during clinical trials.
* Industry experts estimate that by 2011, India's CRO industry market size will reach USD 1 billion. The success of the CRO business model is heavily reliant on project, trial and data management.
* Oracle's clinical applications help automate and effectively manage the clinical phase from study set up through submission.

Supporting Quote

* "We have grown at an aggressive rate for the last three years. To sustain our aggressive growth plans, we are looking at both organic and inorganic growth options across the globe. Oracle's clinical applications are helping us achieve this by delivering a powerful combination of technology and comprehensive business applications, and key functionality built specifically to address the nuances of the CRO industry," said Dr. Chetan Tamhankar, Chief Operating Officer, SIRO Clinpharm.

Supporting Resources

* Oracle Clinical
* Oracle in Health Sciences

About SIRO Clinpharm
SIRO Clinpharm Private Limited (SIRO) is India's oldest and most trusted Clinical Research Organization (CRO), offering full scope services, conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. SIRO is one of the first CROs in India, which caters to the needs of pharmaceutical companies across the globe. SIRO's Clinical Research team carries out comprehensive and independent management of Phase I to Phase IV clinical trials in accordance with the requirements of regulatory authorities and the International Conference on Harmonization of Technical Requirements (ICH) for registration of Pharmaceuticals for human use and guidelines for Good Clinical Practices (GCP). For more information click on http://www.siroclinpharm.com. notas_de_prensa_archivo

<< volver | Portada

  busca y recomienda millones de vídeos  

Advertencia Legal: El contenido de las noticias, comunicados, notas de prensa, actos de agenda y entrevistas aparecidas en esta web es
responsabilidad exclusiva de la empresa u organización que las emite. noticias.info se limita a reproducirlas íntegramente.
© 2002-2008 NoticiasB2B, S.L.; Tel. (+34) 934 523 480 - info@noticias.info; Todos los derechos reservados.